All In Biotech

Free tool

FAERS Monitor: Tonmya

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 219428 or its brand name (Tonmya, Cyclobenzaprine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

8,698

Serious

4,949

57% of reports

Hospitalization

2,222

Death reported

715

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pain1,387
  • headache1,092
  • fatigue1,061
  • drug ineffective811
  • off label use771
  • nausea716
  • constipation711
  • back pain634
  • fall613
  • rheumatoid arthritis551
  • dyspnoea547
  • product dose omission issue519
  • diarrhoea518
  • hypersensitivity517
  • rash514

Reports by year received

View as table
YearReports
2004119
2005123
2006110
200710
200824
200923
201069
2011103
201284
2013130
201497
2015137
2016192
2017206
2018295
2019321
2020480
2021620
2022917
2023942
20241,158
20251,245
20261,292

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,461 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rheumatoid arthritisSignal55111.810.95,432
constipationSignal7117.97.44,313
hypersensitivitySignal5176.86.22,542
back painSignal6346.66.13,041
painSignal1,3875.55.25,203
fallSignal6134.54.11,665
product dose omission issueSignal5194.33.91,314
headacheSignal1,0924.24.02,755
fatigueSignal1,0613.33.11,760
rashSignal5142.92.6629
dyspnoeaSignal5472.32.2429
nauseaSignal7162.22.0479
off label useSignal7712.12.0481
diarrhoea5181.91.8243
drug ineffective8111.51.4138

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.